StopRA


STUDY BASICS

Are you interested in finding out what your risk is for developing rheumatoid arthritis (RA)? If so, you may be eligible to participate in a study to see if medication used daily for 1 year in those with high-risk of developing RA can stop or delay the onset of RA. Participants will undergo a blood draw to determine eligibility. Participation lasts up to 3 years. Compensation is provided.


IRB:
  STUDY19030219 - Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

Age Range
AGE:   18 and Up

Duration DURATION:  up to 3 years

Compensation COMPENSATION: 
Compensation is $10 for completing the blood test. If enrolled in the second part of the study, compensation is up to $650.
I'M INTERESTED
SHARE STUDY
Email A FriendEmail A Friend   FacebookFacebook   TwitterTwitter   Linked-InLinked-In


Pitt+Me

This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.